Cointime

Silexon

company

About

Silexon is an AI-based pharmaceutical research and development service provider.

  • 1 - 10

Highlights

Funding Rounds
1
Investors
2

Details

Last Funding Type
Series A
Industries
Artificial Intelligence,Machine Learning
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Silexon is an AI drug research and development service provider. It is committed to the systematic integration of drug big data using artificial intelligence methods, and deep-enhanced drug development process, specifically involving drug target panorama report, personalized cell therapy, and small molecule virtual screening.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
Silexon has raised a total of — in funding over 2 rounds. Their latest funding was raised on Oct 17, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 17, 2019 Series A — 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Silexon is funded by 2 investors. Shengding Equity Investment Fund and Prosperico Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Shengding Equity Investment Fund — Series A
Prosperico Ventures — Series A
Cointime
เนื้อหา
บริษัท